Language selection

Search

Patent 1303506 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1303506
(21) Application Number: 537360
(54) English Title: DRY POWDERED GERMICIDE AND HEALING COMPOSITION CONTAINING ALLANTOIN AND ASCORBIC ACID
(54) French Title: GERMICIDE SEC EN POUDRE ET COMPOSITION MEDICAMENTEUSE CONTENANT DE L'ALLANTOINE ET DE L'ACIDE ASCORBIQUE
Status: Deemed expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 167/237
(51) International Patent Classification (IPC):
  • A61K 31/415 (2006.01)
(72) Inventors :
  • HECKMANN, RICHARD A. (United States of America)
  • NOORLANDER, DANIEL O. (United States of America)
(73) Owners :
  • HECKMANN, RICHARD A. (Not Available)
  • NOORLANDER, DANIEL O. (Not Available)
(71) Applicants :
(74) Agent: SMART & BIGGAR
(74) Associate agent:
(45) Issued: 1992-06-16
(22) Filed Date: 1987-05-19
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract






ABSTRACT OF THE DISCLOSURE

Nontoxic, dry, powdered germicide, and healing
compositions are disclosed comprising allantoin,
ascorbic acid and an inert powdered carrier.


Claims

Note: Claims are shown in the official language in which they were submitted.



- 7 - 71200-7
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. A dry non-toxic germicide and healing composition
comprising allantoin, ascorbic acid and an inert powdered carrier,
wherein the allantoin is present in an amount of from about 6
percent to about 12 percent by weight and the ascorbic acid is
present in an amount of from about 10 percent to about 20 percent
by weight.



2. A dry non-toxic germicide and healing composition in
accordance with claim 1, wherein the inert carrier is a member
selected from the group consisting of talc, corn starch and
mixtures thereof.



3. A dry non-toxic germicide and healing composition in
accordance with claim 1 or 2, which is adapted for topical
application to a domesticated farm animal.



4. A dry non-toxic germicide and healing composition in
accordance with claim 3, wherein the domesticated farm animal is
dairy cattle.



5. A dry non-toxic germicide and healing composition in

accordance with claim 1 or 2, which is adapted for topical
application to teats of cows.


- 8 - 71200-7
6. A use of a germicide and healing composition for
treating udders of domesticated farm animals to reduce infectious
bacteria thereon by applying topically the said composition to the
teats of the udder, wherein the said composition is a dry non-
toxic germicide and healing composition comprising allantoin,
ascorbic acid and an inert powdered carrier, where the allantoin
is present in the composition in an amount of from about 6 percent
to about 12 percent by weight and the ascorbic acid is present in
the composition in an amount of from about 10 percent to about 20
percent by weight.



7. A use in accordance with claim 6, wherein the inert
carrier is a member selected from the group consisting of talc,
corn starch and mixtures thereof.


Description

Note: Descriptions are shown in the official language in which they were submitted.






DRY POWDERED GERMICIDE AND HEALING COMPOSITIONS

The invention relates to non-toxic, germicide and
healing compositions, and in particular, to such
compositions which are adapted for topical application
to dairy cattle and other domesticated farm animals.

Camfrey (Symphytum officinale) has been reported in
old herbal books as ar back as 200 A.D. as a valuable
medicinal herb to encourage epithelial formation in
wounds, ulcers, and osteomyelitis. An evaluation of the
plant by many investigators has disclosed that
allantoin, a diureide of glyoxylic acid is the active
ingredient found in the comfrey plant that increases the
granulation of damaged tissue in the healing process.
Allantoin can also be formed by the oxidation of uric
acid in most mammals except man and anthropoid apes.
Extensive use, however, oE the comfrey plant or oE its
active ingredient, allantoin, has not been employed in
either human medical treatment or in the area of
veterinary medicine.

'` A principal objective of the present invention is to
provide an effective germicide and healing composition
which can be used in veterinary medicine, particularly
as a sterile, topical dressing Eor inEections in dairy

,
;:~

- 2 - 71200-7
cattle and in treatiny burns, sores and cuts and abrasions ~n
domesticated farm animals. An additional objective of the present
invention is to provide a composition which is active in killing
infec~ious microorganisms such as Staphylococcal and Streptococcal
bacteria. A particular ob~ective of the present invention is to
provide a non-toxic, ~opical dressing which kills many types of
pathogenic bacteria on the surface of skin tissue while at the
same time effecting a rapid healing of the damaged tissue. Another
objective is to provide a non-toxic, germicide and healing
composition which can be used as a topical dressing or
application to dairy cattle in the prevention of mastitis.
The present invention provides a novel, non-toxic,
germicide and healing composition comprising allantoin, ascorbic
acid and an inert, powdered carrier. The present invention also
provides a use of the composition for treating domesticated
animals. The carrier can be any solid material which when applied
in powdered form is inert to the skin and teats of dairy animals
and other farm animals. The carri.er is preferably a member
selected from the group consisting of talc, corn starch and
mlxtures thereof. The concentratlon of the allantoin is yenerally
from about 6 to 12~ by weiyht, and the concentration of ascorbic
acid is generally from about 10~ to 20% by weight. The composition
containing the allantoin, ascorbic acid and a carrier, such as
talc and/or corn starch, in accordance with the present invention
can be produced by simply mixing the separate ingredients
together.
The present invention provides a dry composition in

which the carrier is effective in holding the active ingreclients
,.t~
on the skin surface. The composition is pa`rticularly adapted to be
'~ ' .

3 71200-7
used during cold and wet winter months on the teats of cows. The
dry composition is, of course, effective and advantageously used
throughout the year. In the cold winter months, however, the dry
composition is particularly advantacJeous. A wet composition
applied to the teats of cows during wet and cold atmospheric
conditions can cause chapping and frost damage of the teats. The
dry composltion does not have any such deleterious effect, and a
90% or better reduction in bacteria numbers on the teats of cows
treated with the dry composition c,an be achieved in only 30
minutes' treatment with the composition.
Additional objects and features of the invention will
become apparent from the following detailed description which
describe in particular, preferred embodiments of the invention
representing the best mode presently contemplated of carrying out
the invention.
In accordance with the invention, a non-toxic, germicide
and healing composition is provided comprising ascorbic acid and a
carrier comprising a member selected rom the yroup consistiny of
talc, corn starch and mixtures thereof. The concentration of
allantoin is generally between about 6% and 12% by weiyht, though
an amount sliyhtly more or less than this range may also be
acceptable. The concentration of ascorbic acid ls generally
between about 10% and 20% by weiyht though again an amount
sliyhtly more or less than this ranye may also be acceptable. It
has been found that the dry composition containing allantoin,
ascorbic acid and the carrier is effective in killing many types
of bacteria when applied to skin or tissue in which the bacteria
are found. In addition, the application of the composition
accelerates the

... .
~ ,~
;i !)
.L~^'



healing process for cuts, cracks, etc. in the skin
tissue.

One of the major advanta~es of the composition of
the present invention is that it provides for an
alternative method of treating dairy animals for
mastitis whereby antibiotics are not requirad. Mastitis
is a major bacteria disease of dairy animals which is
cau~;ed by several types of bacteria including
Pseudomonas, Staphylococcus and Streptococcus.
Extensive testing was done to determine the bacteriocide
and healing properties of the dry composition of the
present invention. Laboratory experiments have shown
conclusively that the compositions of this invention are
very effective in killing those type bacteria.

A dry composition containing 10% to 15~ ascorbic
acid, 3~ to 6~ allantoin and the remainder being
essentially talc was applied as a topical agent to the
teats of several cows which showed symptoms of mastitis.
As can be seen from the results as summarized in ~rable
l, a 90~ or better reduction in the number of bactaria
was achieved within 30 minutes after application. I~he
application was repeated twice daily for two or three
days and the cows responded exceptionally well to the
treatment. In essentially all instances, the teats of
the cows no longer showed presence oE mastitis causing
bactaria.
'rA~LE I



Cow Typ~ of 'rime From ~rotal ~otdl Percent ~eduction

No. Sampld Treatl~ent Sacte~la Coccl All coccl

~in.) ~Counts x 1000) ~acterla



1 Swab 0 1707 435

417 3g 76 91


Contact 0 320 183

Pl~te30 61 14 81 91



2 Swab 0 57 34

ll 3 80 92

Contact 0 149 133

Pldta30 9 7 94 95



3 Swab D 1062 992

3~ 35 9 97 99

Contact 0 127 59

Plata30 17 6 87 90



~3506
. ~


In a similar test, a dry composition containing 10
to 15% ascorbic acid, 7% to 10% allantoin and the
remainder being essentially corn starch was applied to
the teats of several cows which showed symptoms of
mastitis. Results, as summari~ed in Table 2I were
similar to those achieved with the composition
containing the dry talc carrier. In Table 2, the number
of bacteria colonies are represented by a scale of 5
being too numerous to count, to 0 being no colonies.

TABLE 2

Cow $ime From Number of
NumberTreatment Bacteria
tMin.) Colonies

4 0 5
2-3


0 4-6
0-1
0

6 0 4-5
0-1
0-1

One bene~it which has been found with the
composition containing corn starch as the carrier
material is that the corn starch is less irritating to


an open cut or incisions on the animal's s]cin. In
controlled tests in which incisions were made in the
test animals, it was found that the incisions treated
with a composition containing the active ingredients
(ascorbic acid and allantoin) in an inert corn starch
carrier healed and closed over somewhat more rapidly
than incisions treated with a composition containing the
same concentration of active ingredients in an inert
talc carrier.

~ aboratory tes-ting has demonstrated that the
compositions of the invention have excellent kill
properties as to various bacteria. Staphylococcal,
Streptococcal, yeastl coliform, pseudomona, and some
fungal microorganisms could be killed in as little as 10
to 45 minutes. Rod shaped organisms with spores are not
killed as rapidly as the spherical shaped streptococcal
and staphylococcal bacteria, but the composition does
act to kill such organisms.

~ lthough preferred embodiments of the invention have
been disclosed, it is to be understood that various
changes and modifications can be made without departing
Erom the subject matter coming within the scope of the
following claims, which subject matter is regarde~ as
the invention~




.~.
-. . ~ ,:
. ,
. .

Representative Drawing

Sorry, the representative drawing for patent document number 1303506 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1992-06-16
(22) Filed 1987-05-19
(45) Issued 1992-06-16
Deemed Expired 1994-12-16

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1987-05-19
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
HECKMANN, RICHARD A.
NOORLANDER, DANIEL O.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1993-11-01 1 12
Claims 1993-11-01 2 50
Abstract 1993-11-01 1 8
Cover Page 1993-11-01 1 15
Description 1993-11-01 6 219